PTC board authorizes $500M stock buyback authorization
PT Therapeutics, Inc. announced its Board of Directors authorized a $500 million share repurchase program to invest in the company. This news might appeal to value investors viewing the undervaluation as an opportunity to acquire shares.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed